Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Isr Med Assoc J ; 20(5): 295-299, 2018 05.
Artigo em Inglês | MEDLINE | ID: mdl-29761675

RESUMO

BACKGROUND: Shortened telomeres were found in patients with cirrhosis, probably reflecting chronic liver injury, continuous regeneration, and destruction of hepatic nodules. OBJECTIVES: To test whether telomere shortening is a general marker of cirrhosis, independent of disease etiology. METHODS: We evaluated telomere length in patients with cryptogenic cirrhosis (largely a late sequela of steatohepatitis) compared to patients with cirrhosis caused by chronic hepatitis B and C (HBV/HCV). We also evaluated telomere aggregates, a sensitive parameter of telomere dysfunction and genetic instability. We analyzed peripheral lymphocytes from 25 patients with cryptogenic cirrhosis, 15 patients with cirrhosis due to chronic viral hepatitis, and 20 age-matched controls. Telomere length was analyzed using quantitative fluorescence in situ hybridization. Aggregate size was divided into three fusion groups of 2-5, 6-10, and 11-15 telomeres, relative to the size of a single telomere. RESULTS: Shorter telomere length was found in patients with cirrhosis from all three etiologies (mean 121.3 ± 24.1) compared to controls (mean 63.5 ± 23.5). In contrast, there was significantly more fusion of > 5 telomeres only in the HBV/HCV cirrhosis group compared to healthy controls (P = 0.023), but not in the cryptogenic cirrhosis group. CONCLUSIONS: While shortened telomeres in peripheral lymphocytes are a general marker of liver cirrhosis, telomere aggregates may signify a more sensitive genetic instability parameter for the diverse, etiology-based malignant potential of cirrhosis. This finding is in agreement with the well-known higher tendency toward developing hepatocellular carcinoma with cirrhosis caused by chronic hepatitis relative to steatohepatitis.


Assuntos
Cirrose Hepática/diagnóstico , Cirrose Hepática/patologia , Telômero/patologia , Feminino , Humanos , Hibridização in Situ Fluorescente , Israel , Fígado/metabolismo , Fígado/patologia , Cirrose Hepática/metabolismo , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Telômero/metabolismo
2.
Isr Med Assoc J ; 20(9): 533-538, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30221864

RESUMO

BACKGROUND: Magnesium is an essential intracellular cation. Magnesium deficiency is common in the general population and its prevalence among patients with cirrhosis is even higher. Correlation between serum levels and total body content is poor because most magnesium is intracellular. Minimal hepatic encephalopathy is a subclinical phase of hepatic encephalopathy with no overt symptoms. Cognitive exams can reveal minor changes in coordination, attention, and visuomotor function, whereas language and verbal intelligence are usually relatively spared. OBJECTIVES: To assess the correlation between intracellular and serum magnesium levels and minimal hepatic encephalopathy. METHODS: Outpatients with a diagnosis of compensated liver cirrhosis were enrolled in this randomized, double-blinded study. Patients were recruited for the study from November 2013 to January 2014, and were randomly assigned to a control (placebo) or an interventional (treated with magnesium oxide) group. Serum and intracellular magnesium levels were measured at enrollment and at the end of the study. Cognitive function was assessed by a specialized occupational therapist. RESULTS: Forty-two patients met the inclusion criteria, 29 of whom were included in this study. Among these, 83% had abnormal cognitive exam results compatible with minimal hepatic encephalopathy. While only 10% had hypomagnesemia, 33.3% had low levels of intracellular magnesium. Initial intracellular and serum magnesium levels positively correlated with cognitive performance. CONCLUSIONS: Magnesium deficiency is common among patients with compensated liver cirrhosis. We found an association between magnesium deficiency and impairment in several cognitive function tests. This finding suggests involvement of magnesium in the pathophysiology of minimal hepatic encephalopathy.


Assuntos
Transtornos Cognitivos/complicações , Encefalopatia Hepática/complicações , Cirrose Hepática/complicações , Deficiência de Magnésio/complicações , Transtornos Cognitivos/diagnóstico , Transtornos Cognitivos/metabolismo , Método Duplo-Cego , Feminino , Encefalopatia Hepática/metabolismo , Humanos , Cirrose Hepática/metabolismo , Deficiência de Magnésio/metabolismo , Óxido de Magnésio/uso terapêutico , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Estudos Prospectivos
3.
Cytogenet Genome Res ; 150(2): 93-99, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-28006764

RESUMO

Nonalcoholic fatty liver disease (NAFLD) and cryptogenic cirrhosis (CC) are considered preneoplastic conditions that might progress to hepatocellular carcinoma. We evaluated parameters of telomere dysfunction in these patient groups to study the correlation between telomere length and the progression of NAFLD. We analyzed peripheral lymphocytes from 22 patients with NAFLD, 20 patients with CC, and 20 healthy, age-matched controls. Telomere length was analyzed using quantitative fluorescence in situ hybridization, and cellular senescence was evaluated by the percentage of cells with senescence-associated heterochromatin foci. The expression of telomerase reverse transcriptase (hTERT) mRNA was measured using polymerase chain reaction, and telomere capture (TC) was assessed with 2 Cytocell probes, 15qter and 13qter. Shorter telomere length and increased cellular senescence was demonstrated in patients with NAFLD, compared to the CC patients and healthy controls. While hTERT mRNA was significantly decreased, TC was increased in CC patients, compared to the NAFLD group and healthy individuals. Thus, there is a correlation between hTERT mRNA expression and telomere length in patients with NAFLD, which might be related to associated metabolic disorders and the risk of malignant transformation. Patients with CC, on the contrary, elongate their telomeres through the TC mechanism.


Assuntos
Cirrose Hepática/congênito , Hepatopatia Gordurosa não Alcoólica/genética , Telômero/genética , Idoso , Estudos de Casos e Controles , Senescência Celular/genética , Progressão da Doença , Feminino , Instabilidade Genômica , Humanos , Cirrose Hepática/genética , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , RNA Mensageiro/genética , Telomerase/genética , Homeostase do Telômero/genética , Encurtamento do Telômero/genética
4.
Hepatogastroenterology ; 60(127): 1713-6, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24634940

RESUMO

BACKGROUND/AIMS: Shortened telomeres reflect genetic instability that might lead to increased aneuploidy and malignant transformations. Chronic hepatitis C (HCV) viral infection is considered a pre-neoplastic condition that might progress to hepatocellular carcinoma. We evaluated telomere length and elongation, in patients with different stages of HCV to study the correlation between telomere length and the progression of HCV. METHODOLOGY: We analyzed peripheral lymphocytes from 10 patients with chronic active HCV, 10 patients with HCV infection in a remission stage, and 10 healthy, age-matched patients, as controls. The expression of hTERT mRNA, which is correlated with elongation of telomeres was measured using RT-PCR and telomere length was analyzed using Q-FISH and a novel computerized technique. RESULTS: hTERT mRNA was significantly decreased in patients with active HCV and slightly decreased in patients who were in remission, compared to healthy individuals. Telomere length was shorter in patients with chronic active HCV and in patients in remission, compared to the healthy controls. CONCLUSIONS: There is a correlation between telomerase reverse transcriptase mRNA expression and telomere length in patients with different stages of HCV infection that might be related to the risk of malignant transformation.


Assuntos
Hepatite C Crônica/enzimologia , RNA Mensageiro/análise , Telomerase/genética , Encurtamento do Telômero , Adulto , Antivirais/uso terapêutico , Estudos de Casos e Controles , Células Cultivadas , Progressão da Doença , Hepatite C Crônica/sangue , Hepatite C Crônica/tratamento farmacológico , Hepatite C Crônica/genética , Humanos , Hibridização in Situ Fluorescente , Linfócitos/enzimologia , Pessoa de Meia-Idade , Indução de Remissão , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Telomerase/sangue , Resultado do Tratamento
5.
Harefuah ; 151(12): 688-91, 720, 2012 Dec.
Artigo em Hebraico | MEDLINE | ID: mdl-23330261

RESUMO

A 48 years old patient was admitted to the Internal Medicine ward due to progressive weakness and abnormal liver function tests. During three months of hospitalization she developed opportunistic infections with Cryptococcus and Pneumocystic jiroveci pneumonia. The CD4+ T-cell lymphocyte count was very low with no evidence of infection with human immunodeficiency virus. Liver disease deteriorated with the appearance of profound jaundice and severe hepatitis. The patient's laboratory and clinical presentation were compatible with the diagnosis of idiopathic CD4 + T-cell lymphocytopenia--ICL. The authors reviewed the literature on ICL and discuss the rare hepatic presentation of this uncommon syndrome.


Assuntos
Criptococose/complicações , Hepatopatias/etiologia , Pneumonia por Pneumocystis/complicações , T-Linfocitopenia Idiopática CD4-Positiva/complicações , Progressão da Doença , Feminino , Humanos , Hepatopatias/fisiopatologia , Testes de Função Hepática , Pessoa de Meia-Idade , Infecções Oportunistas/complicações , Infecções Oportunistas/microbiologia , Pneumocystis carinii/isolamento & purificação , T-Linfocitopenia Idiopática CD4-Positiva/diagnóstico , T-Linfocitopenia Idiopática CD4-Positiva/fisiopatologia
7.
Gene ; 593(1): 162-166, 2016 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-27520584

RESUMO

BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) and cryptogenic cirrhosis (CC), which is largely a late sequela of NAFLD, are considered pre-neoplastic conditions that might progress to hepatocellular carcinoma. Aneuploidy, telomere aggregates and synchronization of replication were evaluated as markers of genetic instability in these patients. METHODOLOGY: Peripheral blood lymphocytes from 22 patients with NAFLD, 20 patients with CC and 20 age-matched healthy controls were analyzed. To determine random aneuploidy, we used the fluorescence in situ hybridization (FISH) with probes for chromosomes 9 and 18. The rate of aneuploidy was inferred from the fraction of cells revealing one, three or more hybridization signals per cell. Aggregate size was divided into three fusion groups of 2-5, 6-10 and 11-15 telomeres, relative to the size of a single telomere. The replication pattern was determined by FISH in two pairs of alleles, 15qter and 13qter. Asynchrony was determined by the presence of one single and one set of double dots in the same cell. RESULTS: Significantly higher random aneuploidy rate was found in the CC patients than in the control group, and to a lesser degree in NAFLD patients. Telomere aggregates were insignificantly higher in both groups. Only patients with CC showed significantly higher rate of asynchronous replication with proportionately more cells with two single dots among the normal cells (p<0.001). CONCLUSIONS: These results likely reflect changes in gene replication and cell cycle progression in these conditions, possibly correlating with their malignant potential.


Assuntos
Alelos , Aneuploidia , Ciclo Celular/genética , Replicação do DNA , Cirrose Hepática , Hepatopatia Gordurosa não Alcoólica , Homeostase do Telômero , Telômero , Idoso , Feminino , Humanos , Cirrose Hepática/genética , Cirrose Hepática/metabolismo , Cirrose Hepática/patologia , Linfócitos/metabolismo , Linfócitos/patologia , Masculino , Pessoa de Meia-Idade , Hepatopatia Gordurosa não Alcoólica/genética , Hepatopatia Gordurosa não Alcoólica/metabolismo , Hepatopatia Gordurosa não Alcoólica/patologia , Telômero/genética , Telômero/metabolismo
9.
Nutrition ; 27(2): 177-81, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20452184

RESUMO

BACKGROUND: Gut flora is related to the major complications of liver cirrhosis including hepatic encephalopathy, spontaneous bacterial peritonitis, and variceal bleeding. Prior studies have reported a beneficial effect of gut flora modification with probiotic bacteria in patients with minimal hepatic encephalopathy. We aimed to study the effect of probiotics on clinical and laboratory parameters of patients with compensated cirrhosis. METHODS: A double-blind placebo-controlled study that included patients with liver cirrhosis and at least one major complication of cirrhosis in the past, clinical evidence of portal hypertension, or decreased hepatic synthetic function. Participants were randomly assigned to receive probiotic capsules containing Lactobacillus acidophilus, Lactobacillus bulgaricus, Bifidobacterium lactis, and Streptococcus thermophiles or placebo for a period of 6 mo. RESULTS: A total of 36 patients were available for final analysis (distributed equally between the probiotic and placebo groups). The administration of probiotics was not associated with significant differences in either clinical or laboratory parameters between the two groups. Because the lack of a beneficial effect may be related to the compensated liver disease of patients, we conducted a subanalysis of patients with baseline ammonia levels > 50 mmol/L. In this subgroup, the administration of probiotics appeared to significantly reduce the ammonia levels starting after 1 mo of treatment. However, this effect diminished and lost its significance following comparison to the placebo group. CONCLUSIONS: Our study did not show a significant beneficial effect of probiotic supplementation in patients with compensated liver cirrhosis. Nevertheless, it points toward a possible positive effect of probiotics in patients with above normal baseline ammonia levels. This issue requires further investigation in larger cohorts.


Assuntos
Amônia/análise , Cirrose Hepática/fisiopatologia , Fígado/fisiopatologia , Probióticos/administração & dosagem , Probióticos/uso terapêutico , Idoso , Amônia/metabolismo , Infecções Bacterianas/terapia , Método Duplo-Cego , Feminino , Seguimentos , Humanos , Hipertensão/terapia , Cirrose Hepática/terapia , Masculino , Pessoa de Meia-Idade , Peritonite/microbiologia , Peritonite/terapia
10.
Cancer Genet Cytogenet ; 191(2): 63-6, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19446739

RESUMO

Broken chromosomes can acquire new telomeres by "telomere capture" (TC), and it has become possible to investigate the terminus in cytogenetically visible telomere rearrangements. The TC phenomenon was observed in malignant conditions. We evaluated the TC rate in hepatitis C virus (HCV) patients compared to non-Hodgkin's lymphoma patients, as well as relative to a control group. For this purpose, we used two Cytocell probes, 15qter and 13qter. Higher TC rates were found in the three study groups relative to the control group. Our results showed that HCV patients have some of the components that can initiate the cascade of events leading to malignancies.


Assuntos
Instabilidade Cromossômica/genética , Hepatite C/patologia , Linfoma não Hodgkin/patologia , Telômero/genética , Telômero/patologia , Técnicas de Cultura de Células , Cromossomos Humanos , Hepatite C/genética , Hepatite C Crônica/genética , Hepatite C Crônica/patologia , Humanos , Hibridização in Situ Fluorescente , Linfócitos/citologia , Linfócitos/patologia , Linfoma não Hodgkin/genética , Recombinação Genética , Valores de Referência , Translocação Genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA